共有 50 笔近期内部人交易记录记录，涉及 Plus Therapeutics, Inc. (PSTV), 包括 48 笔买入 和 0 笔卖出. 内部人买入总额为 $3.16M 内部人卖出总额为 RSU 奖励.
近期活跃的重要内部人包括 Hedrick Marc H, Sims Andrew John Hugh Macintyre, Andrews Ronald Asbury. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — PSTV
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-04-01 |
Hedrick Marc H |
Chief Executive Officer |
期权行权 |
159,681 |
- |
- |
499,468 |
| 2026-04-01 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
期权行权 |
38,323 |
- |
- |
144,784 |
| 2026-03-20 |
Andrews Ronald Asbury |
Director |
未知 |
- |
- |
- |
- |
| 2026-02-25 |
Hedrick Marc H |
Chief Executive Officer |
限制性股票授予 (RSU) |
2,419,582 |
$0.28 |
$677.48K |
2,419,582 |
| 2026-02-25 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
限制性股票授予 (RSU) |
349,541 |
$0.28 |
$97.87K |
349,541 |
| 2026-01-01 |
Hedrick Marc H |
Chief Executive Officer |
期权行权 |
159,681 |
- |
- |
339,787 |
| 2026-01-01 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
期权行权 |
38,323 |
- |
- |
106,461 |
| 2025-11-04 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
知情买入 |
20,000 |
$0.51 |
$10.2K |
68,138 |
| 2025-10-01 |
Hedrick Marc H |
Chief Executive Officer |
期权行权 |
159,681 |
- |
- |
180,106 |
| 2025-10-01 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
期权行权 |
38,323 |
- |
- |
48,138 |
| 2025-08-22 |
Lenk Robert P |
Director |
知情买入 |
110,000 |
$0.49 |
$53.78K |
139,327 |
| 2025-08-13 |
Hedrick Marc H |
Chief Executive Officer |
限制性股票授予 (RSU) |
1,916,168 |
- |
- |
1,916,168 |
| 2025-08-13 |
Hawkins Richard J |
Director |
限制性股票授予 (RSU) |
397,794 |
$0.57 |
$228.49K |
397,794 |
| 2025-08-13 |
Lenk Robert P |
Director |
限制性股票授予 (RSU) |
297,794 |
$0.57 |
$171.05K |
297,794 |
| 2025-08-13 |
Guse Kyle |
Director |
限制性股票授予 (RSU) |
40,000 |
$0.57 |
$22.98K |
40,000 |
| 2025-08-13 |
Van Es-johansson An |
Director |
限制性股票授予 (RSU) |
297,794 |
$0.57 |
$171.05K |
297,794 |
| 2025-08-13 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
限制性股票授予 (RSU) |
459,878 |
- |
- |
459,878 |
| 2025-08-13 |
Clowes Howard |
Director |
限制性股票授予 (RSU) |
297,794 |
$0.57 |
$171.05K |
297,794 |
| 2025-04-18 |
Guse Kyle |
Director |
未知 |
- |
- |
- |
- |
| 2025-02-18 |
Hedrick Marc H |
Chief Executive Officer |
限制性股票授予 (RSU) |
400,489 |
$1.18 |
$472.58K |
400,489 |
| 2025-02-18 |
Hawkins Richard J |
Director |
限制性股票授予 (RSU) |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2025-02-18 |
Lenk Robert P |
Director |
限制性股票授予 (RSU) |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2025-02-18 |
Petersen Greg |
Director |
限制性股票授予 (RSU) |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2025-02-18 |
Van Es-johansson An |
Director |
限制性股票授予 (RSU) |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2025-02-18 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
限制性股票授予 (RSU) |
60,020 |
$1.18 |
$70.82K |
60,020 |
| 2025-02-18 |
Clowes Howard |
Director |
限制性股票授予 (RSU) |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2024-09-13 |
Hawkins Richard J |
Director |
知情买入 |
4,000 |
$1.50 |
$6K |
15,188 |
| 2024-09-12 |
Hawkins Richard J |
Director |
知情买入 |
6,285 |
$1.35 |
$8.51K |
11,188 |
| 2024-09-11 |
Hedrick Marc H |
Chief Executive Officer |
限制性股票授予 (RSU) |
197,595 |
$1.26 |
$248.97K |
197,595 |
| 2024-09-11 |
Hawkins Richard J |
Director |
限制性股票授予 (RSU) |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Lenk Robert P |
Director |
限制性股票授予 (RSU) |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Petersen Greg |
Director |
限制性股票授予 (RSU) |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Van Es-johansson An |
Director |
限制性股票授予 (RSU) |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
限制性股票授予 (RSU) |
46,074 |
$1.26 |
$58.05K |
46,074 |
| 2024-09-11 |
Clowes Howard |
Director |
限制性股票授予 (RSU) |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Petersen Greg |
Director |
知情买入 |
12,500 |
$1.35 |
$16.88K |
48,921 |
| 2024-09-11 |
Clowes Howard |
Director |
知情买入 |
5,000 |
$1.34 |
$6.68K |
26,497 |
| 2024-09-10 |
Hedrick Marc H |
Chief Executive Officer |
知情买入 |
8,000 |
$1.23 |
$9.84K |
20,425 |
| 2024-09-10 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
知情买入 |
4,098 |
$1.27 |
$5.2K |
9,815 |
| 2024-05-08 |
Hedrick Marc H |
Chief Executive Officer |
知情买入 |
12,255 |
$2.04 |
$25K |
12,425 |
| 2024-05-08 |
Hawkins Richard J |
Director |
知情买入 |
4,902 |
$2.04 |
$10K |
4,903 |
| 2024-05-08 |
Lenk Robert P |
Director |
限制性股票授予 (RSU) |
8,334 |
$1.79 |
$14.92K |
8,334 |
| 2024-05-08 |
Petersen Greg |
Director |
限制性股票授予 (RSU) |
24,510 |
$1.79 |
$43.87K |
24,510 |
| 2024-05-08 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
知情买入 |
4,902 |
$2.04 |
$10K |
5,717 |
| 2024-05-08 |
Clowes Howard |
Director |
限制性股票授予 (RSU) |
19,608 |
$1.79 |
$35.1K |
19,608 |
| 2024-02-22 |
Hedrick Marc H |
Chief Executive Officer |
限制性股票授予 (RSU) |
94,012 |
$2.03 |
$190.84K |
94,012 |
| 2024-02-22 |
Hawkins Richard J |
Director |
限制性股票授予 (RSU) |
2,250 |
$2.03 |
$4.57K |
2,250 |
| 2024-02-22 |
Lenk Robert P |
Director |
限制性股票授予 (RSU) |
2,250 |
$2.03 |
$4.57K |
2,250 |
| 2024-02-22 |
Lafrance Norman D. |
Chief Medical Officer |
限制性股票授予 (RSU) |
24,073 |
$2.03 |
$48.87K |
24,073 |
| 2024-02-22 |
Petersen Greg |
Director |
限制性股票授予 (RSU) |
2,250 |
$2.03 |
$4.57K |
2,250 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
